Abzena

Abzena is a leading provider of integrated solutions for the biopharmaceutical industry, dedicated to advancing the development of new therapies. With a strong focus on quality and innovation, Abzena offers a comprehensive range of services that span from early-stage discovery through to clinical development and commercialisation.

Founded with the vision of supporting the pharmaceutical sector, Abzena combines expertise in protein engineering, cell line development, and process optimisation. The company prides itself on its ability to tailor solutions to meet the specific needs of its clients, ensuring that each project is handled with the utmost care and precision.

Abzena’s state-of-the-art facilities are equipped with cutting-edge technology, enabling the team to deliver high-quality results efficiently. The company’s commitment to scientific excellence is reflected in its robust quality management systems, which adhere to the highest regulatory standards.

Core Services:

• Protein Engineering: Customised solutions for antibody and protein design.
• Cell Line Development: Rapid generation of high-yield production cell lines.
• Process Development: Scalable processes for manufacturing biologics.
• Analytical Services: Comprehensive testing to ensure product integrity.

With a global presence, Abzena collaborates with a diverse range of clients, from small biotech firms to large pharmaceutical companies. The company’s mission is to accelerate the delivery of life-saving therapies to patients worldwide, making a significant impact on public health.

Abzena is not just about business; it is about building partnerships based on trust and mutual success. The team is passionate about science and dedicated to pushing the boundaries of what is possible in drug development.